ArticleThe Journal of clinical investigation2019

PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer.

Roman M Chabanon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.